Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
NCT02069665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 451
Last updated 2014-02-24
Summary
The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial.
Conditions
Interventions
- OTHER
-
Fuxiong San
external application; 8-10cm wide, 0.3-0.5cm thick; 10mins for patient aged 1 to 3-year old; 15mins for those aged 3 to 5-year old; once daily
- DRUG
-
Xiyanping injection
ivd. 5 to 10 mg/(kg•d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection.
- DRUG
-
Ribavirin Injection
ivd. 10 to 20 mg/(kg•d), plus 5% Glucose Injection, 80 to 100 ml, ivd. Once a day injection.
- DRUG
-
Xiaoer Qingfei Heji (mixture)
children aged 6 months to 1 year old: 10 ml, orally taken three times daily; children aged 1 to 3 year old: 15 ml, orally taken three times daily; children aged 3 to 5 year old: 20 ml, orally taken three times daily;
- DRUG
-
Zhi Ke San
children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily;
- DRUG
-
Hua Tan San
children aged 6 months to 1 year old: 0.5g, orally taken three times daily; children aged 1 to 3 year old: 1.5g, orally taken three times daily; children aged 3 to 5 year old: 2.0g, orally taken three times daily;
- DRUG
-
Guaifenesin Syrup
children aged 6 months to 1 year old: 3ml, orally taken three times daily; children aged 1 to 3 year old: 5ml, orally taken three times daily; children aged 3 to 5 year old: 8ml, orally taken three times daily;
- DRUG
-
Ibuprofen Suspension
taken under prescription
- DRUG
-
salbutamol
taken under prescription
Sponsors & Collaborators
-
Beijing University of Chinese Medicine
collaborator OTHER -
Liaoning University of Traditional Chinese Medicine
lead OTHER
Principal Investigators
-
Xuefeng Wang, Ph.D. · Affiliated Hospital of Liaoning University of TCM
-
Zhenqi Wu · Affiliated Hospital of Liaoning University of TCM
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Months
- Max Age
- 59 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2013-07-31
- Completion
- 2013-08-31
Countries
- China
Study Locations
More Related Trials
-
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
NCT04251871 ·Status: UNKNOWN ·Phase: NA
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186 ·Status: UNKNOWN ·Phase: PHASE2
-
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)
NCT06220019 ·Status: NOT_YET_RECRUITING
-
Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials
NCT03147443 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine
NCT02937207 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
NCT05672498 ·Status: UNKNOWN ·Phase: NA
-
Effects of Traditional Chinese Medicine on Bronchiectasis Patients
NCT03443531 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections
NCT07206745 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluating the Efficacy and Safety of Modified Qing-Zao-Jiu-Fei Decoction on Pneumoconiosis Patients
NCT07178184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study
NCT01769794 ·Status: COMPLETED ·Phase: NA
-
Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD
NCT06455670 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TCM for Coal Worker's Pneumoconiosis
NCT04841200 ·Status: UNKNOWN ·Phase: NA
-
A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method
NCT04601792 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study on the Treatment of Chronic Airway Diseases (Asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie
NCT06691802 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of Huashibaidu Granule on Community-acquired Pneumonia in Children
NCT05711017 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study on the Efficacy and Safety of Qingre Heji in the Treatment of Acute Upper Respiratory Tract Infection
NCT06520618 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Traditional Chinese Medicine for Severe COVID-19
NCT04323332 ·Status: UNKNOWN ·Phase: PHASE3
-
REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)
NCT06373692 ·Status: NOT_YET_RECRUITING
-
A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
NCT01145664 ·Status: UNKNOWN ·Phase: NA
-
TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease
NCT07295938 ·Status: RECRUITING ·Phase: PHASE2
-
Effectiveness of Chinese Herbal Therapy for Asthma
NCT00712296 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population
NCT00965822 ·Status: COMPLETED ·Phase: PHASE2
-
Study on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial Asthma
NCT04128111 ·Status: UNKNOWN
-
Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children
NCT04457011 ·Status: COMPLETED ·Phase: PHASE2
-
Public Title:A Study on the Registration of The Use of Feilike HeJi in Adults
NCT04714489 ·Status: UNKNOWN